An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses.
- DOI
- 10.1016/j.bcp.2026.118339
- Published
- 2026 Nov
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118339,
title = {An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses.},
author = {Li Q and Lin J and Gao F and Wang X and Ma Y and Zhang C and Wu H and Zhao F and Song Y and Xu M and He W and Zhao K and Liu G and Guan J},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118339},
url = {https://doi.org/10.1016/j.bcp.2026.118339}
}RIS
TY - JOUR TI - An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses. AU - Li Q AU - Lin J AU - Gao F AU - Wang X AU - Ma Y AU - Zhang C AU - Wu H AU - Zhao F AU - Song Y AU - Xu M AU - He W AU - Zhao K AU - Liu G AU - Guan J PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118339 UR - https://doi.org/10.1016/j.bcp.2026.118339 ER -
APA
Q, L., J, L., F, G., X, W., Y, M., C, Z., H, W., F, Z., Y, S., M, X., W, H., K, Z., G, L., & J, G. (2026). An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118339
Source records
- pubmed · retrieved 2026-09-26T19:14:41.425Z